ARCHIVES

RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment

This article is from The Cancer Letter archive.

Vol. 36 No. 9 | September 27, 2013

Download PDF Visit The Full Archive

Related Articles

Young Early-Stage Patients Can Preserve Fertility

August 28, 2009

List of core grants renewed in FY 2003, full list of center grants.

January 16, 2004

Push to Get Exceptions, Adjustments For Clinical Research In DRG Regulations Gaining Momentum

July 22, 1983

NTP Board Plans Peer Review Of Bioassay Reports

April 11, 1980

FDA will return memento given to McClellan by NCI Director Andrew von Eschenbach.

February 6, 2004

In Brief: Forel Retires As Dana-Farber Director, Successor Is David Livingston; Benacerraf Plans Departure

July 5, 1991